Popular Articles

The 32nd British Transplant Games 30th July - 2nd August 2009
This year the British Transplant Games takes place in Coventry and 900 transplant athletes are preparing to take part. For a handful of these athletes, the Games offers vital training and preparation for other major sporting challenges such as triathlons and marathons. The event organisers, Transplant Sport UK shines the spotlight on these inspiring people, who visibly demonstrate that there is life after transplant, allowing them to train to a high level of fitness against all the odds.

Pioneering Research Into Healing Power Of Sugar
A pioneering University of Wolverhampton lecturer has won a ÷£25,000 grant to research the healing effect of sugar on cuts and wounds.
News of the day
Three Hospitals Honored For Commitment To Quality
Three U.S. hospitals were recognized today for their leadership and innovation in quality, safety and commitment to patient care. The 2009 American Hospital Association-McKesson Quest for Quality Prize® was awarded to Bronson Methodist Hospital in Kalamazoo, Mich., which will receive $75,000. Bronson Methodist Hospital, a 380-bed hospital serving patients and communities in southwest Michigan and northern Indiana, was selected by a multi-disciplinary committee of health care quality and patient safety experts based on its culture of quality and efforts to achieve the Institute of Medicine"s six quality aims for health care. Beth Israel Deaconess Medical Center in Boston was honored as the finalist and will receive $12,500. Duke University Hospital in Durham, N.C., received the Citation of Merit.
Diagnostics

Data Presented At The 5th International AIDS Society Conference Suggests Low Testosterone Frequently Goes Undetected In HIV-Positive Men

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, announced that new data from the two-part HYHYHI Study (Hypogonadal Hypotestosteronism in HIV-Seropositive Men) were presented as a poster today at the 5th International AIDS Society (IAS) Conference in Cape Town, South Africa. This retrospective chart review, supported by the Company, evaluated the challenges associated with diagnosing low testosterone in men with HIV/AIDS. The study also compared the difference in testosterone levels achieved after 12 months of treatment with either Testim® 1% (testosterone gel) or AndroGel®, two commonly used FDA-approved testosterone replacement products. Results from the study showed that when using the more sensitive Free Testosterone test (FT About the Study The HYHYHI study, designed and conducted by Dr. Blick, was a retrospective chart review of men with HIV/AIDS screened for Low T and treated with testosterone replacement therapy. Data were collected from two U.S. sites and included 400 men diagnosed with HIV/AIDS and screened for Low T, defined as Total T About Testim Testim is a proprietary, clear, topical gel containing 1% testosterone, the same type of hormone that is produced by the human body. When applied once-daily to the upper arms and shoulders, clinical studies have shown that Testim will restore and maintain testosterone levels. Once Testim is absorbed through the skin, it enters the bloodstream and helps return testosterone to normal levels. The efficacy of Testim has been demonstrated in 16 clinical studies involving approximately 1,800 patients, including the largest placebo-controlled study ever conducted to evaluate the benefits and risks of testosterone replacement therapy. Auxilium estimates that approximately 76 million tubes, or daily applications, of Testim have been used since the product was launched in 2003. For information regarding the safety and use of Testim, please see the prescribing information at http://www.testim.com. Auxilium Pharmaceuticals, Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):